Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pain 13Pain, Postoperative 10Neoplasms 8Agnosia 8Multiple Myeloma 7Cancer Pain 5Breast Neoplasms 5Lung Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Head and Neck Neoplasms 3Colonic Neoplasms 3Trigger Finger Disorder 2Lymphoma 2Hodgkin Disease 2Hematologic Neoplasms 2Ganglion Cysts 2De Quervain Disease 2Chronic Pain 2Burkitt Lymphoma 2Acute Pain 2Vomiting 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Strabismus 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Melanoma × Acetaminophen × Clear all
NCT00003346 2013-06-25

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
80 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡